Sirion Therapeutics
About:
Sirion Therapeutics is a biopharmaceutical company, engaged in developing, and commercializing of products for the protection of eyesight.
Website: https://www.siriontherapeutics.com/
Top Investors: Advent International, Atlas Venture, Aisling Capital, Novaquest Capital Management, Investor Growth Capital Limited
Description:
Sirion Therapeutics is a Tampa, FL-based company dedicated to the development and commercialization of innovative ophthalmic products.
Total Funding Amount:
$45M
Estimated Revenue Range:
$10M to $50M
Headquarters Location:
Tampa, Florida, United States
Founded Date:
2005-01-01
Founders:
Barry Butler, Philippe Boulangeat
Number of Employees:
101-250
Last Funding Date:
2007-04-10
IPO Status:
Private
Industries:
© 2025 bioDAO.ai